Kathleen Borthwick
Chief Financial Officer, Passage BIO, Inc.
Companies
- Passage BIO, Inc.Chief financial officer Jul 28, 2023 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Passage BIO, Inc. PASG5,402 shares2$18.6K at $3.44Jan 8, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 8, 2026Sold 2,062 shares at $18.44 of Passage BIO, Inc.2
- Jan 8, 2026Exercised options 5,000 shares of Passage BIO, Inc.2
- Feb 11, 2025Sold 3,183 shares at $0.53 of Passage BIO, Inc.3
- Feb 10, 2025Exercised options 8,000 shares of Passage BIO, Inc.3
- Feb 13, 2024Sold 1,470 shares at $0.97 of Passage BIO, Inc.4
- Feb 10, 2024Exercised options 4,000 shares of Passage BIO, Inc.4
- Jan 2, 2024Sold 10,672 shares at $0.91 of Passage BIO, Inc.5
- Dec 31, 2023Exercised options 30,000 shares of Passage BIO, Inc.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Feb 12, 2025
- 4SEC EDGARForm 4 filed Feb 13, 2024
- 5SEC EDGARForm 4 filed Jan 3, 2024